{"id":"NCT00440310","sponsor":"Light Sciences Oncology","briefTitle":"Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases","officialTitle":"A Multicenter Multinational Phase 3 Randomized Study to Evaluate the Safety and Efficacy of Treating Colorectal Cancer Patients With Recurrent Liver Metastases Using the Litx™ System Plus Chemotherapy as Compared to Chemotherapy Only","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-02","primaryCompletion":"2011-05","completion":"2011-10","firstPosted":"2007-02-27","resultsPosted":"2015-08-25","lastUpdate":"2015-08-25"},"enrollment":483,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Liver Metastases","Colorectal Neoplasms","Neoplasm Metastasis","Neoplasm Recurrence, Local"],"interventions":[{"type":"DRUG","name":"Talaporfin sodium","otherNames":[]},{"type":"PROCEDURE","name":"Percutaneous placement of device in liver metastases","otherNames":[]},{"type":"DEVICE","name":"Interstitial light emitting diodes","otherNames":[]},{"type":"DRUG","name":"FOLFOX4 regimen","otherNames":[]},{"type":"DRUG","name":"FOLFIRI regimen","otherNames":[]}],"arms":[{"label":"Litx + Chemotherapy","type":"EXPERIMENTAL"},{"label":"Chemotherapy alone","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to assess the overall survival and progression free survival of patients treated with Litx™ + chemotherapy versus chemotherapy alone in the treatment of Colorectal Cancer with recurrent liver metastases, and to demonstrate the safety of Litx™ therapy.\n\nLitx™ consists of a light-activated drug, talaporfin sodium (LS11, Light Sciences Oncology, Bellevue, Washington), and a light generating device, composed of light-emitting diodes (LEDs), that is energized by a power controller and percutaneously placed in the target tumor tissue inside the body.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"Up to 184 weeks","effectByArm":[{"arm":"Litx + Chemotherapy","deltaMin":390,"sd":null},{"arm":"Chemotherapy Alone","deltaMin":405,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":12},"locations":{"siteCount":57,"countries":["Austria","Bosnia and Herzegovina","Croatia","Germany","India","Italy","Latvia","Poland","Romania","Russia","Serbia","Sweden","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":66,"n":222},"commonTop":["Nausea","Procedural pain","Fatigue","Neutropenia","Diarrhoea"]}}